» Articles » PMID: 12378365

A Systematic Review of Health State Utility Values for Osteoporosis-related Conditions

Overview
Journal Osteoporos Int
Date 2002 Oct 16
PMID 12378365
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

An important weakness of economic models in the field of osteoporosis has been the dependence on assumptions or expert judgements rather than empirical estimates for the utility values of key health events associated with osteoporosis such as hip, vertebral, wrist fracture and established osteoporosis. This paper seeks to identify the best available utility estimates for health states associated with osteoporosis and make recommendations about their use. It is based on a systematic search of the main literature databases. Studies meeting inclusion criteria have been reviewed in terms of the appropriateness of the valuation technique, the validity of the descriptive system (if one was used), the number and type of respondents, and overall quality of the study. Twenty three estimates of health state values (HSVs) were found across the four conditions from five studies. These empirical estimates were found to differ significantly from the commonly used assumptions in economic evaluation, but with a wide variation between estimates for the same state (0.32 to 0.80 for vertebral fracture states). This variation can be partly explained by the valuation technique, health state description and the background and perspective of respondent, and leaves scope for considerable discretion that could be abused. There are also problems in using values obtained from the study populations to those in economic models and the difficulty of predicting health state values in those who avoid a fracture. The review recommends a set of health state values as part of a "reference case" for use in economic models. Due to the paucity of good quality of estimates in this area, further recommendations are made regarding the design of future studies to collect HSVs relevant to economic models.

Citing Articles

Health-related quality of life in men with osteoporosis: a systematic review and meta-analysis.

Hu J, Zheng W, Zhao D, Sun L, Zhou B, Liu J Endocrine. 2021; 74(2):270-280.

PMID: 34165773 DOI: 10.1007/s12020-021-02792-0.


Patient-Level Modeling Approach Using Discrete-Event Simulation: A Cost-Effectiveness Study of Current Treatment Guidelines for Women with Postmenopausal Osteoporosis.

Le Q J Manag Care Spec Pharm. 2019; 25(10):1089-1095.

PMID: 31556816 PMC: 10397705. DOI: 10.18553/jmcp.2019.25.10.1089.


Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States.

Le Q, Hay J, Becker R, Wang Y Ann Pharmacother. 2018; 53(2):134-143.

PMID: 30160186 PMC: 6311620. DOI: 10.1177/1060028018798034.


Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.

Su Y, Lai F, Yip B, Leung J, Kwok T Osteoporos Int. 2018; 29(8):1793-1805.

PMID: 29774400 DOI: 10.1007/s00198-018-4543-4.


Cost-effectiveness of Virtual Bone Strength Testing in Osteoporosis Screening Programs for Postmenopausal Women in the United States.

Agten C, Ramme A, Kang S, Honig S, Chang G Radiology. 2017; 285(2):506-517.

PMID: 28613988 PMC: 5673038. DOI: 10.1148/radiol.2017161259.